BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22284350)

  • 1. How chemoproteomics can enable drug discovery and development.
    Moellering RE; Cravatt BF
    Chem Biol; 2012 Jan; 19(1):11-22. PubMed ID: 22284350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery libraries targeting the major enzyme classes: the serine hydrolases.
    Otrubova K; Srinivasan V; Boger DL
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3807-13. PubMed ID: 25037918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding chemogenomic space using chemoproteomics.
    Jones LH
    Bioorg Med Chem; 2019 Aug; 27(15):3451-3453. PubMed ID: 31221609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoproteomic-enabled phenotypic screening.
    Conway LP; Li W; Parker CG
    Cell Chem Biol; 2021 Mar; 28(3):371-393. PubMed ID: 33577749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.
    Petrilli WL; Adam GC; Erdmann RS; Abeywickrema P; Agnani V; Ai X; Baysarowich J; Byrne N; Caldwell JP; Chang W; DiNunzio E; Feng Z; Ford R; Ha S; Huang Y; Hubbard B; Johnston JM; Kavana M; Lisnock JM; Liang R; Lu J; Lu Z; Meng J; Orth P; Palyha O; Parthasarathy G; Salowe SP; Sharma S; Shipman J; Soisson SM; Strack AM; Youm H; Zhao K; Zink DL; Zokian H; Addona GH; Akinsanya K; Tata JR; Xiong Y; Imbriglio JE
    Cell Chem Biol; 2020 Jan; 27(1):32-40.e3. PubMed ID: 31653597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics of kinase inhibitor targets and mechanisms.
    Daub H
    ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical proteomics and discovery of drug targets].
    Yang HQ; Li XJ
    Yao Xue Xue Bao; 2011 Aug; 46(8):877-82. PubMed ID: 22007509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors.
    Liao D
    Drug Discov Today Technol; 2015 Nov; 18():24-8. PubMed ID: 26723889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing Suzuki Coupling Reagents as a Directed Fragment Library Targeting Serine Hydrolases and Related Enzymes.
    Lanier M; Cole DC; Istratiy Y; Klein MG; Schwartz PA; Tjhen R; Jennings A; Hixon MS
    J Med Chem; 2017 Jun; 60(12):5209-5215. PubMed ID: 28564542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target identification for biologically active small molecules using chemical biology approaches.
    Lee H; Lee JW
    Arch Pharm Res; 2016 Sep; 39(9):1193-201. PubMed ID: 27387321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical proteomics to identify molecular targets of small compounds.
    Sun B; He QY
    Curr Mol Med; 2013 Aug; 13(7):1175-91. PubMed ID: 23826922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule Inhibitors of
    Shehaj L; Choudary SK; Makwana KM; Gallo MC; Murphy TF; Kritzer JA
    ACS Infect Dis; 2019 Jul; 5(7):1129-1138. PubMed ID: 31016966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Druggability Assessment for Selected Serine Proteases in a Pharmaceutical Industry Setting.
    Wehrhan L; Hillisch A; Mundt S; Tersteegen A; Meier K
    ChemMedChem; 2020 Nov; 15(21):2010-2018. PubMed ID: 32776472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical proteomics in drug discovery.
    Drewes G
    Methods Mol Biol; 2012; 803():15-21. PubMed ID: 22065215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Progress of methodology for identifying target protein of natural active small molecules].
    Tu PF; Zeng KW; Liao LX; Song XM
    Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(1):6-13. PubMed ID: 28845631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of small molecule bioactive probes in the identification of cellular targets].
    Zhang J; Zhou HC
    Yao Xue Xue Bao; 2012 Mar; 47(3):299-306. PubMed ID: 22645752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of small-molecule modulator of heterotrimeric G
    Kawamura T; Futamura Y; Shang E; Muroi M; Janning P; Ueno M; Wilke J; Takeda S; Kondoh Y; Ziegler S; Watanabe N; Waldmann H; Osada H
    Biosci Biotechnol Biochem; 2020 Dec; 84(12):2484-2490. PubMed ID: 32867616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.